Yes, if there really was a flood of inbound enquiries, as expressed by RV in the quarterly call of April 2023, the six months lead time should have meant a significant increase in sales in Q224, yet sales then were disappointing. So was there ever a flood of enquiries?Or were the salespeople unable to clinch the sales?PB seems to have brought all the staff to work together; even Dr Chen is making a real contribution (according to the call). As far as I know,
Dr Vicini was not so active on Impedimed's behalf.
Has anyone else thought what I have, how both honest, even brave, it was to say a pipeline of 300?
With a lead time of six months, everyone will be expecting something special in Q125.
Ann: Investor Presentation, page-39
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.002(3.28%) |
Mkt cap ! $119.3M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.3¢ | 5.9¢ | $50.81K | 833.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 250506 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 121721 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IPD (ASX) Chart |